<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Oral hypoglycaemic agents become less effective as beta cell function declines </plain></SENT>
<SENT sid="1" pm="."><plain>Thus many patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> will ultimately require treatment with insulin </plain></SENT>
<SENT sid="2" pm="."><plain>There are two main approaches to starting insulin: (a) as a basal supplement with an intermediate to long-acting preparation (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NPH</z:e>, glargine or detemir) plus oral agents; (b) as a premixed insulin regimen </plain></SENT>
<SENT sid="3" pm="."><plain>Almost <z:hpo ids='HP_0000001'>all</z:hpo> the studies have shown similar <z:chebi fb="105" ids="17234">glucose</z:chebi> control with both <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NPH</z:e> and the new insulin analogs </plain></SENT>
<SENT sid="4" pm="."><plain>Further analyses between these insulins have documented significant reductions in <z:e sem="disease" ids="C0020615" disease_type="Disease or Syndrome" abbrv="">hypoglycaemia</z:e> especially at night with the insulin analogs </plain></SENT>
<SENT sid="5" pm="."><plain>The <z:mp ids='MP_0005456'>weight gain</z:mp> is an important issue in patients with <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>It appears that insulin detemir studies have reported weight neutrality or less weigh gain or even <z:hpo ids='HP_0001824'>weight loss</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>However, most insulin glargine studies have reported a <z:mp ids='MP_0005456'>weight gain</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>On the other hand insulin analogs have the important disadvantage of high cost </plain></SENT>
<SENT sid="9" pm="."><plain>It is important to take in to account <z:hpo ids='HP_0000001'>all</z:hpo> the above factors such as cost, <z:mp ids='MP_0005456'>weight gain</z:mp>, number of insulin injections and <z:e sem="disease" ids="C0020615" disease_type="Disease or Syndrome" abbrv="">hypoglycaemia</z:e> while prescribing insulin </plain></SENT>
</text></document>